CLINICAL_TRIALS
research
· 2026-03-05
Clinical Trial Update: CLF065 for Chronic Pouchitis [Phase 2]
Summary
A Phase 2 study of CLF065 for chronic pouchitis is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Calibr, a division of Scripps Research | Conditions: Pouchitis | Phase 2 | Status: RECRUITING